Dr. Beth Oates

Dr. Beth Oates

Dr. Beth Oates

Dr. Beth Oates received her PhD in Microbiology, Immunology, and Molecular Genetics from the University of Kentucky, College of Medicine, where her research focused on bacterial competition and antimicrobial mechanisms. She previously served as a Young Ambassador to the American Society for Microbiology and has worked with various non-profit organizations to advocate on behalf of scientists and trainees. In 2021, Dr. Oates completed the Science Policy Fellowship with Federation of American Societies for Experimental Biology, where she focused on crafting public communications on complex scientific topics such as research animal transportation and National Institute of Health policy. At Gryphon, Dr. Oates utilizes her background in scientific communication to inform the public on influenza and coronavirus research and policy recommendations.

Beth loves to travel and find hidden gems for food. She claims that the best mojito can be found at an Italian restaurant in Bacharach, Germany. However, without a doubt, Kentucky has the best bourbon.

Dr. Holly May

Dr. Holly May

Dr. Holly May

Dr. Holly May is a microbiologist with an expertise in infectious disease and host-pathogen interactions. At Gryphon, her work focuses on scientific data management and analysis to support influenza and coronavirus surveillance and research. Prior to joining Gryphon, Dr. May received her PhD in Cell and Molecular Biology from the University of Texas at San Antonio and completed her post-doctoral training at the Naval Medical Research Unit-San Antonio, where her research focused on multi-drug resistant bacteria and bacteriophage therapy. She also previously served as a Young Ambassador to the American Society for Microbiology, where she worked on community outreach and education initiatives.

Holly is an avid traveler and video game enthusiast. She thrives on exploration, be it riding camels through the Sahara, backpacking in the shadows of Mt. Rainier, or exploring the virtual ruins of Kaer Morhen.

Glen Noble

Dr. Glen Noble

Dr. Glen Noble

Glen Noble

Dr. Glen Noble

Dr. Glen Noble brings to Gryphon over 20 years of experience in medicinal chemistry and 17 years in chemical database management. Dr. Noble holds a PhD in medicinal chemistry, and his research interests include developing radiopharmaceuticals useful for mapping biological receptors. Dr. Noble was first introduced to chemical database management at GlaxoSmithKline and Eli Lilly and Company. At Gryphon, Dr. Noble supports NIAID’s ChemDB database, a chemical structure-based database containing quantitative biological information on compounds tested against HIV, tuberculosis and other related opportunistic pathogens.

You’d expect an incredibly methodical data base manager to like crossword and jigsaw puzzles. But his love of Sci-fi and fantasy books breaks the mold.

Emily Billings

Dr. Emily Billings

Dr. Emily Billings

Emily Billings

Dr. Emily Billings

Dr. Emily Billings is a microbiologist with expertise in the mechanisms through which microbes and the body communicate to drive health and disease. An advocate of multidisciplinary research, her doctoral studies on host-pathogen interactions at the University of Virginia required expertise in bacteriology, immunology, cell biology, advanced imaging, and molecular biology techniques. At Gryphon, Dr. Billings focuses on projects with data management, outreach, and science communications components that enable the application of research to policy and public health challenges. She combines scientific expertise with design skills to create meaningful end products to communicate findings and support decision-making for technical and non-technical audiences. She has a particular interest in infectious disease and biosurveillance analytics and data visualization.

Emily has a penchant for graphic design, watercolor, and resin art. A once and future midfielder, she’s also been seen acing set plays on the soccer field. 

Andrew Burnham

Dr. Andrew Burnham

Dr. Andrew Burnham

Andrew Burnham

Dr. Andrew Burnham

Dr. Andrew Burnham is an infectious disease biologist who earned his PhD in Molecular, Cellular, and Developmental Biology from Indiana University and completed a fellowship at St. Jude Children’s Research Hospital where he worked on antiviral resistance of influenza viruses. His research focused on influenza B virus as well as H5N1 and emerging H7N9 influenza A viruses. Joining Gryphon in 2014, he has focused on collecting and analyzing human and animal surveillance and viral sequence data for infectious disease projects, most notably the NIH funded Centers of Excellence for Influenza Research and Surveillance (CEIRS).

Andrew collects vintage video games and is an amateur auto mechanic who can be found adventuring under the family’s cars or in pull-a-part car lots scavenging for replacement parts.